Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?

Grossmann, Mathis

Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia? [electronic resource] - The Journal of clinical endocrinology and metabolism Oct 2014 - 3625-8 p. digital

Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment

1945-7197

10.1210/jc.2014-3290 doi


Androgen Antagonists--adverse effects
Body Mass Index
Humans
Immunoglobulin Fc Fragments--adverse effects
Male
Muscle, Skeletal--drug effects
Myostatin--antagonists & inhibitors
Prostatic Neoplasms--drug therapy
Recombinant Fusion Proteins--adverse effects